Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 7, 2003

View Archived Issues

Pharmacopeia and Novartis collaborate on lead compound discovery

Pharmacopeia and Celgene enter inflammatory collaboration

Schering claims novel ligands and metal complexes for use as imaging agents

Novel tyrosine kinase inhibitors in Merck pipeline

Leo Pharma validates psoriasis target from Switch Biotech

Vion awarded SBIR grant for further Tapet studies

Licensing and development activity at Serono

Solvay presents new antiarrhythmic potassium channel blockers

Dual 5-HT2B/H1 antagonist discovered at Biofrontera

Tricyclic antitumor agents covered by Yung Shin patent

Almirall Prodesfarma claims adenosine A2B antagonists for use in asthma and other disorders

Inhibitors of HCV NS5B polymerase identified at GSK

Researchers at Northwestern U. identify novel nNOS inhibitors

InterMune updates idiopathic pulmonary fibrosis programs

Genzyme looks forward to 2003

ZymoGenetics initiates rFXIII phase I trials, signs exclusive licensing agreement

Corixa reacquires North American rights to lung cancer vaccines

Schering AG acquires Japanese and Asian rights to Campath

Millennium submits MAA for Velcade in E.U.

Transition Therapeutics completes acquisition of Stem Cell Therapeutics

Nonamphetamine MAO-B inhibitor protects against MPTP-induced dopamine depletion

Controlled delivery of EYE-001 encapsulated in PLGA microspheres

Improved BBB permeability of NXY-059 under ischemic conditions

BX-471: discovery and preclinical profile discussed at recent scientific meeting

Potent, small-molecule IL-2/IL-2Ralpha antagonist designed at Sunesis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...